Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine
Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine
复制标题
DOI：
10.1016/j.vaccine.2011.03.076
复制
发表时间：
2011-06-06
期刊：
影响因子：
5.5
通讯作者：
Tiro, Jasmin A.
中科院分区：
文献类型：
--
作者：
Price, Rebecca Anhang;Koshiol, Jill;Tiro, Jasmin A.
背景：如果接受人乳头状瘤病毒(HPV)疫苗接种的妇女对接种疫苗的癌症预防益处过于放心，她们可能会选择不参与筛查，从而增加她们患宫颈癌的风险。这项研究评估了成年女性对接种HPV疫苗后继续进行宫颈癌筛查的知识，描述了接种疫苗的年轻成年女性的巴氏检测意图，并评估了宫颈癌最高风险人群之间的知识和意图是否存在差异。方法：数据来自2008年健康信息全国趋势调查(HINTS)和2008年全国健康访谈调查(NHIS)，该调查在FDA首次批准HPV疫苗约18个月后开始收集数据。结果：在1586名年龄在18岁至74岁的女性受访者中，95.6%的人知道接种了HPV疫苗的女性应该继续接受巴氏检测。这些知识没有因种族/民族、教育、收入或医疗保健机会而有显著差异。在1 101名18~26岁接受过巴氏杆菌检测的女性中，报告接种过人乳头状瘤病毒疫苗的比例(12.7%)比未接种的人计划在3年内接受巴氏杆菌检测的比例(98.1%比92.5%，p<；0.001)更高。绝大多数在HPV疫苗上市头两年内接种的年轻成年女性打算在不久的将来参加宫颈癌筛查。未来的研究需要检查那些在青春期接种疫苗的人是否会在他们符合条件时意识到并遵守筛查指南。(C)2011爱思唯尔有限公司。保留所有权利。
Background: If women who receive the human papillomavirus (HPV) vaccine are unduly reassured about the cancer prevention benefits of vaccination, they may choose not to participate in screening, thereby increasing their risk for cervical cancer. This study assesses adult women's knowledge of the need to continue cervical cancer screening after HPV vaccination, describes Pap test intentions of vaccinated young adult women, and evaluates whether knowledge and intentions differ across groups at greatest risk for cervical cancer.Methods: Data were from the 2008 Health Information National Trends Survey (HINTS) and the 2008 National Health Interview Survey (NHIS), which initiated data collection approximately 18 months after the first FDA approval of an HPV vaccine. We calculated associations between independent variables and the outcomes using chi-square tests.Results: Of 1586 female HINTS respondents ages 18 through 74,95.6% knew that HPV-vaccinated women should continue to receive Pap tests. This knowledge did not vary significantly by race/ethnicity, education, income, or healthcare access. Among 1101 female NHIS respondents ages 18-26 who had ever received a Pap test, the proportion (12.7%; n=139) who reported receipt of the HPV vaccine were more likely than those not vaccinated to plan to receive a Pap test within three years (98.1% vs. 92.5%, p < 0.001).Conclusions: US adult women possess high knowledge and intention to participate in Pap testing after HPV vaccination. The vast majority of young adult women who received the HPV vaccine within its first two years on the market intend to participate in cervical cancer screening in the near future. Future studies are needed to examine whether those vaccinated in adolescence will become aware of, and adhere to, screening guidelines as they become eligible. (C) 2011 Elsevier Ltd. All rights reserved.